ABSTRACT
Sneddon syndrome may present with neurological findings such as transient ischemic stroke, strokes, seizures and/or headaches. However, a purplish, spider web-like skin finding called livedo reticularis may accompany the skin and precede neurological findings. Sneddon syndrome often affects women. Since it is vasculopathy affecting small and medium vessels, other organ findings may accompany. We present a 44-year-old Sneddon syndrome patient with monoparesis in her left lower extremity, livedo reticularis on her back and legs, and hypertension.
Subject(s)
Antiphospholipid Syndrome , Livedo Reticularis , Sneddon Syndrome , Stroke , Humans , Female , Adult , Sneddon Syndrome/complications , Sneddon Syndrome/diagnosis , Livedo Reticularis/complications , Stroke/etiology , Skin , Antibodies, Antiphospholipid , Antiphospholipid Syndrome/complications , Antiphospholipid Syndrome/diagnosisSubject(s)
Sneddon Syndrome , Humans , Sneddon Syndrome/complications , Sneddon Syndrome/diagnosis , SkinABSTRACT
The term Sneddon's syndrome (SS) has been used since 1965 to describe a vasculopathy characterized by a combination of cerebrovascular disease with livedo racemosa. SS may be classified as antiphospholipid+ (aPL+) or antiphospholipid- (aPL-). Little is known about aPL- SS; in this review we describe the epidemiology and pathogenesis of aPL- SS, as well as the clinical and histologic features. We discuss recent findings in terms of neurologic and cardiac involvement. Moreover, differential diagnoses of conditions that may present with both livedo racemosa and stroke are discussed. Finally, we discuss real-life practical issues such as the initial investigations to be performed, long-term follow-up, and therapeutic management of aPL- SS patients.
Subject(s)
Antiphospholipid Syndrome , Livedo Reticularis , Sneddon Syndrome , Antiphospholipid Syndrome/complications , Antiphospholipid Syndrome/diagnosis , Antiphospholipid Syndrome/epidemiology , Diagnosis, Differential , Humans , Livedo Reticularis/diagnosis , Livedo Reticularis/epidemiology , Livedo Reticularis/etiology , Sneddon Syndrome/complications , Sneddon Syndrome/diagnosis , Sneddon Syndrome/epidemiologyABSTRACT
BACKGROUND: Sneddon syndrome (SS) is defined by widespread livedo reticularis (LR) and stroke. There is no single diagnostic test for SS and diagnosis can be solely based on clinical features. This cross-sectional case-control study aimed to determine the diagnostic value of skin biopsies in SS patients. MATERIALS AND METHODS: We studied skin biopsies from patients with a clinical diagnosis of SS or isolated LR. We also studied controls with vitiligo or normal skin. Biopsies were considered standardized if 3 biopsies were taken from the white centre of the livedo and reached until the dermis-subcutis border. Biopsies were scored for features of an occlusive microangiopathy without knowledge of the clinical features. Sensitivity and specificity of the biopsy findings were calculated with the clinical criteria as the reference standard. RESULTS: We included 34 SS patients, 14 isolated LR patients and 41 control patients. Biopsies of 17 patients with SS (50%), 4 with isolated LR (31%) and 10 control patients (24%) showed at least one artery in the deep dermis with a thickened vessel wall combined with recanalization or neovascularization (sensitivity 50% and specificity 69% with LR as reference). Standardized biopsies increased the sensitivity to 70%. In a post hoc analysis the combination of an occlusive microangiopathy and the presence of a livedo pattern in the superficial dermis increased the specificity to 92%. CONCLUSIONS: Standardized skin biopsies can support the clinical diagnosis of SS. An occlusive microangiopathy as the only positive criterion for the diagnosis of SS had insufficient specificity for a definite diagnosis.
Subject(s)
Skin , Sneddon Syndrome , Adolescent , Adult , Aged , Biopsy , Female , Humans , Male , Middle Aged , Retrospective Studies , Risk Factors , Sensitivity and Specificity , Skin/blood supply , Skin/pathology , Sneddon Syndrome/diagnosis , Sneddon Syndrome/pathology , Vitiligo/diagnosis , Vitiligo/pathologyABSTRACT
BACKGROUND: The presence of livedo reticularis in patients with ischaemic stroke is associated with Sneddon syndrome (SS). Our objective was to present the clinical features of SS patients and to assess the role of antiphospholipid antibodies (APL). METHODS: Consecutive patients, diagnosed with SS between 1996 and 2017, were retrospectively reviewed for their demographic, neurological, dermatological, cardiac and extracerebral vascular features. Diagnosis of SS was made only if other causes of stroke were excluded. Patients with and without APL were included and compared for their clinical features. RESULTS: Fifty-three patients (79% female) were included, of whom 14 patients were APL-positive. Median age at diagnosis was 40 years. Approximately 60% of the patients had ≥ 3 cardiovascular risk factors. There were 129 previous vascular events (66 ischaemic strokes, 62 TIAs and 1 amaurosis fugax) during a median period of 2 years between the first event and diagnosis of SS. Skin biopsy was positive for SS in 29 patients (67%), mostly showing a thickened vessel wall with neovascularization in the deep dermis. After a median follow-up of 28 months, 4 patients, either on antiplatelet or oral anticoagulation therapy, had a recurrent stroke. There were few statistically significant differences between APL-negative and APL-positive patients, including the number of vascular events before diagnosis. CONCLUSIONS: SS predominantly affects young women with a relatively large number of cardiovascular risk factors. Clinical features of SS are comparable across different studies. We found no differences in the main clinical features between APL-positive and APL-negative patients.
Subject(s)
Antiphospholipid Syndrome , Brain Ischemia , Sneddon Syndrome , Stroke , Antibodies, Antiphospholipid , Brain Ischemia/complications , Brain Ischemia/epidemiology , Female , Humans , Male , Retrospective Studies , Sneddon Syndrome/complications , Sneddon Syndrome/diagnosis , Sneddon Syndrome/epidemiology , Stroke/complications , Stroke/epidemiology , Stroke/therapyABSTRACT
Herein, we report a case-based review of the Sneddon Syndrome (SS), a rare chronic condition which affects small to medium blood vessels. It is known by its skin presentation, livedo racemosa (LRC), and the relapsing cerebrovascular events. However, neither LRC nor cerebrovascular events are exclusive to SS. A 36-year-old female with history of mitral valve prolapse, hypothyroidism, Raynaud phenomenon, hypertension, migraines, and four episodes of transient ischemic attacks (TIA), presented to our clinic with new skin findings, suggestive of LRC. Based on her previous history, current presentation and skin biopsy results, she was diagnosed with SS secondary to antiphospholipid syndrome. The present report illustrates the difficulty in recognizing SS and how the heterogeneity of the disease may be contributing to the difficulty making a distinct diagnosis.
Subject(s)
Antiphospholipid Syndrome/diagnosis , Sneddon Syndrome/diagnosis , Adult , Antiphospholipid Syndrome/complications , Antiphospholipid Syndrome/drug therapy , Antirheumatic Agents/administration & dosage , Factor Xa Inhibitors/administration & dosage , Female , Humans , Hydroxychloroquine/administration & dosage , Rivaroxaban/administration & dosage , Skin/pathology , Sneddon Syndrome/complications , Sneddon Syndrome/drug therapyABSTRACT
No disponible
Subject(s)
Humans , Female , Aged , Skin Diseases, Vesiculobullous/diagnosis , Sneddon Syndrome/diagnosis , Diagnosis, Differential , Exanthema/diagnosisABSTRACT
TITLE: Ictus recidivante, acrocianosis y livedo racemosa: ¿siempre síndrome de Sneddon?
Subject(s)
Angiomatosis/diagnosis , Brain Diseases/diagnosis , Raynaud Disease/etiology , Sneddon Syndrome/diagnosis , Stroke/etiology , Adult , Angiomatosis/complications , Angiomatosis/diagnostic imaging , Brain Diseases/complications , Brain Diseases/diagnostic imaging , Cerebral Angiography , Cognition Disorders/etiology , Diagnosis, Differential , Female , Headache/etiology , Humans , Magnetic Resonance Imaging , Neuroimaging , Recurrence , SyndromeABSTRACT
We present the case of a 58-year-old woman with multiple brain infarcts and livedo racemosa, a distinctive branched and irregular skin discoloration, on the trunk and limbs. Skin biopsy showed intimal proliferation with occlusion of a subcutaneous arteriole. We diagnosed Sneddon's syndrome, a rare neurocutaneous disorder likely caused by a noninflammatoryvasculopathy.
Subject(s)
Brain Infarction/etiology , Skin Diseases/etiology , Sneddon Syndrome/diagnosis , Biopsy , Brain/pathology , Brain Infarction/pathology , Female , Humans , Middle Aged , Skin/pathology , Skin Diseases/diagnosis , Sneddon Syndrome/complications , Vascular Diseases/etiologyABSTRACT
In this case report, a 28-year-old woman known with slight aortic regurgitation presented with partial complex epileptic seizures. On examination, livedo reticularis was noted, and cerebral MRI scans showed signs of clinical silent old lacunar infarctions. She was persistently triple positive for antiphospholipid antibodies in high titres and fulfilled the antiphospholipid syndrome criteria. The patient was diagnosed with Sneddon's syndrome, which is a rare thrombotic vasculopathy characterised by the combination of cerebrovascular disease with livedo reticularis. Her seizures stopped, after anticoagulation therapy with warfarin was initiated.
Subject(s)
Antiphospholipid Syndrome , Sneddon Syndrome , Stroke , Adult , Antibodies, Antiphospholipid , Antiphospholipid Syndrome/complications , Antiphospholipid Syndrome/diagnosis , Female , Humans , Seizures , Sneddon Syndrome/complications , Sneddon Syndrome/diagnosis , Stroke/complications , Stroke/diagnosisSubject(s)
Erythema Multiforme/diagnosis , Sneddon Syndrome/diagnosis , Stroke/diagnosis , Adult , Biopsy, Needle , Diagnosis, Differential , Erythema Multiforme/complications , Erythema Multiforme/pathology , Female , Humans , Immunohistochemistry , Magnetic Resonance Imaging/methods , Prognosis , Risk Assessment , Sneddon Syndrome/pathology , Stroke/complicationsABSTRACT
BACKGROUND: The association that exists between livedo reticularis (LR) and stroke is known as Sneddon's syndrome (SnS). The disorder is classified as primary SnS (PSnS), if the cause remains unknown and secondary SnS. The condition is rare and it occurs mainly sporadically. In 2014, 2 independent teams described a new genetic disorder with childhood-onset, which was called deficiency of adenosine deaminase 2 (DADA2), characterized by recurrent fevers and vascular pathologic features that included LR and stroke. All the patients carried recessively inherited mutations in cat eye syndrome chromosome region candidate 1 gene (CECR1), encoding the adenosine deaminase 2 (ADA2) protein. Genetic testing is the standard for the diagnosis of DADA2. However, the diagnostic accuracy of more affordable laboratorial analysis in CECR1-mutated individuals remains to be established. We aim to determine whether plasma ADA2 activity and serum immunoglobulin M (IgM) levels can distinguish (1) DADA2 from other adult patients within the SnS spectrum, and (2) healthy CECR1 heterozygous (HHZ) from healthy controls (HC). METHODS: ADA2 activity in plasma and serum IgM concentrations was measured in adult patients within the SnS spectrum, healthy first-degree relatives and HC. Genetic results were used as the reference standard. The primary outcome measures were sensitivity and specificity derived from receiver operating curve analysis. RESULTS: A total of 73 participants were included in the study: 26 patients with PSnS with no CECR1 mutation (PSnS), 6 bi-allelic (DADA2 patients) and 7 HHZ CECR1 mutations and 34 HC. Plasma ADA2 activity and serum IgM levels were significantly lower in DADA2 patients than in PSnS. With the use of the best indexes, plasma ADA2 activity differentiated PSnS from DADA2 with a sensitivity and specificity of 100.0% and HHZ from HC with a sensitivity of 97.1% and specificity of 85.7%. Serum IgM levels also differentiated PSnS from DADA2 with a sensitivity of 85.2% and specificity of 83.3%. CONCLUSION: Serum IgM levels might be used as a triage tool and plasma ADA2 activity performs perfectly as a diagnostic test for DADA2 in adult patients within the SnS spectrum. ADA2 activity in plasma also reliably distinguishes HHZ from HC.
Subject(s)
Adenosine Deaminase/blood , Immunoglobulin M/blood , Intercellular Signaling Peptides and Proteins/blood , Sneddon Syndrome/diagnosis , Adenosine Deaminase/genetics , Adult , Biomarkers/blood , Case-Control Studies , DNA Mutational Analysis , Databases, Factual , Diagnosis, Differential , Female , Genetic Predisposition to Disease , Heterozygote , Homozygote , Humans , Intercellular Signaling Peptides and Proteins/genetics , Male , Middle Aged , Mutation , Phenotype , Predictive Value of Tests , Prognosis , Sneddon Syndrome/enzymology , Sneddon Syndrome/genetics , Sneddon Syndrome/immunology , Young AdultABSTRACT
Sneddon syndrome (SS) is a rare condition and the diagnosis is made only when other more common disease entities have been excluded. Common manifestations in SS patients include hypertension, coronary artery disease, venous thrombosis, miscarriages, psychiatric disturbances, and arterial and venous thrombotic events. Most patients present in their early 30s with classic neurovascular and dermatologic signs. Currently, the main criteria for the diagnosis of SS include livedo racemosa, focal neurological deficits or evidence of stroke on magnetic resonance imaging, or characteristic vascular alterations seen on biopsy. We present the case of a 37-year-old woman with extensive livedo racemosa, chronic migraine headaches, splenomegaly, and lymphadenopathy. Cutaneous biopsies demonstrated a superficial perivascular lymphocytic infiltrate without the subendothelial proliferative changes or fibrosis seen in some patients with SS. The patient's medical history suggested idiopathic livedo racemosa with possible full progression to SS. This case highlights the variability in the clinical presentation of SS and that the disease often can be diagnosed before neurovascular events. Earlier diagnosis can lead to prevention of chronic occlusive neurovascular manifestations and irreversible damage such as myocardial infarction and stroke. Familiarity with the highly variable early course of SS can aid in diagnosis and reduction of morbidity and mortality that is associated with this disease.
Subject(s)
Livedo Reticularis/diagnosis , Lymphadenopathy/diagnosis , Sneddon Syndrome/diagnosis , Splenomegaly/diagnosis , Adult , Female , Humans , Livedo Reticularis/etiology , Livedo Reticularis/pathology , Lymphadenopathy/etiology , Sneddon Syndrome/complications , Splenomegaly/etiologySubject(s)
Nicolau Syndrome/diagnosis , Nicolau Syndrome/pathology , Skin/pathology , Sneddon Syndrome/diagnosis , Sneddon Syndrome/pathology , Atrophy , Cerebral Ventricles/pathology , Diagnosis, Differential , Female , Humans , Ischemia/diagnosis , Ischemia/pathology , Middle Aged , Posterior Leukoencephalopathy Syndrome/diagnosis , Posterior Leukoencephalopathy Syndrome/pathology , Skin/blood supply , Thrombosis/diagnosis , Thrombosis/pathologyABSTRACT
No disponible
Subject(s)
Humans , Female , Adult , Sneddon Syndrome/complications , Sneddon Syndrome/diagnosis , Lymphoma, Non-Hodgkin/complications , Lymphoma, Non-Hodgkin/drug therapy , Lymphoma, Non-Hodgkin , Lymphoma, Large B-Cell, Diffuse/drug therapy , Lymphoma, Large B-Cell, Diffuse , Stroke/complications , Stroke , Aphasia/complications , Magnetic Resonance Imaging/methods , Magnetic Resonance Spectroscopy/methods , Rituximab/therapeutic use , Cyclophosphamide/therapeutic use , Doxorubicin/therapeutic use , Vincristine/therapeutic use , Prednisone/therapeutic useABSTRACT
Divry van Bogaert Syndrome (DBS) is a familial juvenile-onset disorder characterized by livedo racemosa, white matter disease, dementia, epilepsy and angiographic finding of "cerebral angiomatosis". A similar syndrome including livedo racemosa and cerebrovascular disease, often associated with anticardiolipin antibodies, has been described as Sneddon Syndrome (SS) highlighting the question whether these two conditions have to be considered different entities or indeed different features of a unique syndrome. Herein, we report the clinical, neuroradiological, histopathological findings and follow up of three cases diagnosed as Divry-van Bogaert Syndrome, including an updated review of literature of both DBS and SS cases. Our findings support the assumption that DBS and SS are different disease entities. DBS is characterized by the typical angiographic feature of angiomatosis, a hereditary trait and a juvenile onset of cognitive impairment and leukoaraiosis, whereas SS has less severe manifestations of cerebrovascular disease associated with livedo racemosa but without the characteristic cerebral angiography. The report of our cases and the literature review underline the necessity of a detailed work-up and the collection of larger series to better clarify the DBS and SS phenotype and course.